| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |